The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-β on human hematopoiesis

Blood

Volumn 91, Issue 6, 1998, Pages 1917-1923

  Bruno, Edward ^a   Horrigan, Stephen K ^a   Van Den Berg, David ^a   Rozler, Elen ^a   Fitting, Priscilla R ^a   Moss, Steven T ^a   Westbrook, Carol ^a   Hoffman, Ronald ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CD34 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL PROLIFERATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0032521421     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.1917.1917_1917_1923     Document Type: Article

References (51)

1. Bagby GC Jr, Segal GM: Growth factors and the control of hematopoiesis, in Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology: Basic Principles and Practice. New York, NY, Churchill Livingstone, 1995, p 207
2. Bruno E, Luikart SD, Long MW, Hoffman R: Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol 23:1212, 1995
3. Long MW, Briddell R, Walter AW, Bruno E, Hoffman R: Human hematopoietic stem cell adherence to cytokines and matrix molecules. J Clin Invest 90:251, 1992
4. Gordon MY, Greaves MF: Physiological mechanisms of stem cell regulation in bone marrow transplantation and haemopoiesis. Bone Marrow Transplant 4:335, 1989
5. Ryan DH, Tang J: Regulation of human B cell lymphopoiesis by adhesion molecules and cytokines. Leuk Lymphoma 17:375, 1995
6. Brandt J, Srour EF, van Besien K, Briddell RA, Hoffman R: Cytokine-dependent long term culture of highly enriched precursers of hematopoietic progenitor cells from human marrow. J Clin Invest 82:1017, 1988
7. Bruno E, Briddell R, Hoffman R: Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Exp Hematol 16:371, 1988
8. Bruno E, Miller ME, Hoffman R: Interacting cytokines regulate in vitro human megakaryocytopoiesis. Blood 73:671, 1989
9. Bruno E, Hoffman R: Effect of interleukin 6 on in vitro human megakaryocytopoiesis: Its interaction with other cytokines. Exp Hematol 17:1011, 1989
10. Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, Hoffman R: In vivo administration of recombinant methionyl human stem cell factor expands the number of human hematopoietic stem cells. Blood 82:784, 1993
11. Quesenberry PJ, Ihle JN, McGrath E: The effect of interleukin-3 and GM CSA-2 on megakaryocyte and myeloid clonal colony formation. Blood 65:214, 1985
12. Emerson SG, Yang Y-C, Clark SC, Long MW: Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities. J Clin Invest 82:1282, 1988
13. Nemunaitis J: Cytokine-mobilized peripheral blood progenitor cells. Semin Oncol 23:9, 1996
14. Peschel C, Paul WE, Ohara J, Green I: Effects of B cell stimulating factor-1/interleukin 4 on hematopoietic progenitor cells. Blood 70:254, 1987
15. Sawada K, Sato N, Koike T: Inhibition of GM-CSF production by recombinant human interleukin-4: Negative regulator of hematopoiesis. Leuk Lymphoma 19:33, 1995
16. Valent P: Cytokines involved in growth and differentiation of human basophils and mast cells. Exp Dermatol 4:255, 1995
17. Bruno E, Briddell RA, Cooper RJ, Hoffman R: Effects of recombinant interleukin-11 on human megakaryocyte progenitor cells. Exp Hematol 19:378, 1991
18. Goldman SJ: Preclinical biology of interleukin 11: A multifunctional hematopoietic cytokine with potent throbopoietic activity. Stem Cells (Dayt) 13:462, 1995
19. Du XX, Williams DA: Interleukin-11: A multifunctional growth factor derived from the hematopoietic microenvironment. Blood 83: 2023, 1994
20. Kibayashi S, Telamura M, Oshinni K, Mizoguchi: Interleukin-11. Leuk Lymphoma 15:45, 1994
21. Hassan HT, Zauder A: Stem cell factor as a survival and growth factor in human, normal and malignant hematopoiesis. Acta Haematol 95:257, 1996
22. Segal GM, McCall E, Stueve T, Bagby GC Jr: Interleukin 1 stimulates endothelial cells to release multilineage human colony stimulating activity. J Immunol 138:172, 1987
23. Briddell RA, Bruno E, Cooper RJ, Brandt JE, Hoffman R: Effect of c-kit ligand on in vitro human megakaryocytopoiesis. Blood 78:2854, 1991
24. Bruno E, Cooper RJ, Wilson EL, Gabrilovic JL, Hoffman, R: Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood 82:430, 1993
25. Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove J: Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 77:954, 1991
26. Keller JR, Sing GK, Ellingsworth LR, Ruscetti FW: Transforming growth factor β: Possible roles in the regulation of normal and leukemic hematopoietic cell growth. J Cell Biochem 39:175, 1988
27. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039, 1987
28. Sporn MB, Roberts AB: Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119:1017, 1992
29. Stinicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH: Transforming growth factor β directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood 88:82, 1996
30. Hatzfeld J, Li M-L, Brown EL, Sookdeo H, Levesque J-P, O'Toole T, Gurney C, Clark SC, Hatzfeld A: Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β or Rb oligonucleotides. J Exp Med 174:925, 1991
31. Sing GK, Keller JR, Ellingsworth LR, Ruscetti FW: Transforming growth factor β selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 72:1504, 1988
32. Ottmann OG, Pelus LM: Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells. J Immunol 140:2661, 1988
33. Jacobsen SEW, Keller JR, Ruscetti FW, Kondaiah P, Roberts AB, Falk LA: Bidirectional effects of transforming growth factor β (TGF-β) on colony-stimulating factor-induced human myelopoiesis in vitro: Differential effects of distinct TGF-β isoforms. Blood 78:2239, 1991
34. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B: Mad-related genes in the human. Nature Genet 13:347, 1996
35. Hursh DA, Padgett RW, Gelbart WM: Cross regulation of decapentaplegic and ultrabithorax transcription in the embryonic visceral mesoderm of Drosophilia. Development 117:1211, 1993
36. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM: Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophilia melanogaster. Genetics 139:1347, 1995
37. Savage C, Das P, Finelli AL, Townsend SR, Sun C-Y, Baird SE, Padgett RW: Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor β pathway components. Proc Natl Acad Sci USA 93:790, 1996
38. Horrigan SK, Westbrook CA, Kim AH, Banerjee M, Stock W, Larson RA: Polymerase chain reaction-based diagnosis of Del(5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 88:2665, 1996
39. Hannon K, Smith CK II, Bales KR, Stavnezer RF: Temporal and quantitative analysis of myogenic regulatory and growth factor gene expression in the developing mouse embryo. Dev Biol 151:137, 1992
40. Methia N, Louache F, Vainchenker W, Wendling F: Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82:1395, 1993
41. Coller BS, Peerschke EI, Seligsohn V, Scudder LE, Nurden AT, Rosa J-P: Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor. J Lab Clin Med 107:384, 1986
42. Cheifetz S, Weatherbee JA, Tsang M L-S, Anderson JK, Mole JE, Lucas R, Massagué J: The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409, 1987
43. Massagué J: Receptors for the TGF-β family. Cell 69:1067, 1992
44. Ridley AJ, Davis JB, Stroobant P, Land H: Transforming growth factors-β1 and β2 are mitogens for rat Schwann cells. J Cell Biol 109:3419, 1989
45. Cheifetz S, Hernadez H, Laiho M, ten Dijke P, Iwata KK, Massagué J: Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Bio Chem 265:20533, 1990
46. Jennings JC, Mohan S, Linkhart TA, Widstrom R, Baylink DJ: Comparison of the biological actions of TGF beta-1 and TGF beta-2: Differential activity in endothelial cells. J Cell Physiol 137:167, 1988
47. Ohta M, Greenberger JS, Anklesaria P, Bassols A, Massagué J: Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells. Nature 329:539, 1987
48. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massagué J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175, 1990
49. Kim S-J, Lee H-D, Robbins PD, Busam K, Sporn MB, Roberts AB: Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma-susceptability gene. Proc Natl Acad Sci USA 88:3052, 1991
50. Massagué J, Polyak K: Mammalian antiproliferative signals and their targets. Curr Opin Genet Dev 5:91, 1995
51. Hahn SA, Schutte M, Shamsul Hoque ATM, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor supressor gene at human chromosome 18q21.1. Science 271:350, 1996